Northwestern University Feinberg School of Medicine
Skip to main content

Cancer Nanotechnology

The T32 Postdoctoral Training Program in Cancer Nanotechnology is an NCI-funded, two-year program that consists of research, educational and career development components to prepare participants for academic and related careers in translational cancer nanotechnology.

Fellows enrolled in the training program will acquire the skills and knowledge to design cancer nanomaterials, to investigate their biological properties and to evaluate their safety and efficacy. In addition to the Lurie Cancer Center, Northwestern University’s International Institute for Nanotechnology, the Simpson Querry Institute for BioNanotechnology and an NCI-funded Center of Cancer Nanotechnology Excellence all provide resources for the training program.

Qualified PhDs and MDs are encouraged to apply. Applicants must be U.S. citizens or permanent residents. For further information about the program and application instructions, please contact the program director, Gayle Woloschak, PhD, or the program administrator, Benette Phillips, PhD.

Research Mentors


Vadim Backman, PhD
Professor, Biomedical Engineering
Novel optical methods to interrogate cellular nanoscale architecture

Chonghui Cheng, MD, PhD
Assistant Professor, Medicine
Detection of live circulating breast tumor cells using NanoFlares

Susan Clare, MD, PhD
Research Associate Professor, Surgery
Nano-based therapies for breast cancer metastases to the brain

Vinayak Dravid, PhD
Professor, Materials Science and Engineering
Magnetic nanoconstructs that can simultaneously detect and treat tumors

Leo Gordon, MD
Professor, Medicine
Synthetic HDL gold nanoparticles to treat B-cell lymphomas

John Kessler, MD
Professor, Neurology
DNA-peptide nanotubes that enhance neural stem cell differentiation

Andrew Larson, PhD
Professor, Radiology
Nanoparticles to plan and monitor radioembolization of liver tumors

Maciej Lesniak, MD
Professor and Chair, Neurological Surgery
Nanomaterials to image and treat glioblastomas

Thomas Meade, PhD
Professor, Chemistry
Nanomaterials for multimodal imaging of tumors

Chad Mirkin, PhD
Professor, Chemistry
Design of nanoparticle-based tools for cancer diagnosis and for therapeutic modulation of gene expression

Milan Mrksich, PhD
Professor, Biomedical Engineering
Bioactive material-based assays to study cancer cell behavior

SonBinh Nguyen, PhD
Professor, Chemistry
Polymer-based nanoparticles to deliver cancer therapeutics

Thomas O'Halloran, PhD
Professor, Chemistry
Tumor-targeted nanobins to treat breast and ovarian cancer

Teri Odom, PhD
Professor, Chemistry
Gold nanostars for nuclear-targeted therapy

Amy Paller, MD
Professor, Dermatology
Spherical nucleic acid nanoconstructs for skin cancer treatment

Alexander Stegh, PhD
Assistant Professor, Neurology
Polyvalent RNAi gold nanoparticles to treat gliomas

Samuel Stupp, PhD
Professor, Materials Science and Engineering
Biomedical applications of bioactive nanostructures

C. Shad Thaxton, MD, PhD
Assistant Professor, Urology
Nanoparticle therapeutics, imaging agents and biosensors

Gayle Woloschak, PhD
Professor, Radiation Oncology
Photoactivatable titanium dioxide bionanocomposites for anti-cancer applications

Back to top